C16 Lactosylceramide is an endogenous bioactive sphingolipid. It forms membrane microdomains with Lyn kinase and the αi subunits of inhibitory G protein-coupled receptors (GPCRs), suggesting a role in cell signaling. Plasma levels of C16 lactosylceramide are elevated in insulin-resistant cattle. C16 Lactosylceramide is also upregulated in a mouse model of Niemann-Pick type C1 disease, a neurodegenerative cholesterol-sphingolipid lysosomal storage disorder.

4201-62-1

C46H87NO13

862.18

C16 Lactosylceramide (d18:1/16:0)

Chloroform:Methanol:H2O (2:1:0.1):Soluble
Powder: -20°C for 3 years
In solvent: -80°C for 2 years